2024 Drug Pricing Pharmaceutical Companies 
STAT
MARCH 18, 2024
The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. Continue to STAT+ to read the full story…
STAT
OCTOBER 18, 2024
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
FEBRUARY 7, 2024
And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures. healthcare expenditures.
STAT
JULY 6, 2023
Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us. The company hopes to launch the product in the U.S. in 2024.
STAT
JANUARY 11, 2024
WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests. Continue to STAT+ to read the full story…
PharmaState Academy
MARCH 6, 2024
This quiz competition is brought to you by Pharma Industry Townhall – Sales & Marketing scheduled for 16th March 2024 at Radisson Blue, Marol, Andheri East, Mumbai. a) Medical Research b) Marketing Representative c) Medication Review d) Market Regulation MR' commonly refers to Marketing Representative in pharmaceutical marketing.
STAT
OCTOBER 21, 2024
WASHINGTON — Most executives at pharmaceutical companies haven’t directly donated to political candidates over the final stretch of the 2024 campaign. 30, five gave to Democratic candidates, even though Democratic lawmakers passed the most aggressive drug pricing reform in decades in 2022.
Expert insights. Personalized for you.
363 
Let's personalize your content